MVP
ACOR

Missouri Valley Partners’s Acorda Therapeutics ACOR Stock Holding History

Missouri Valley Partners’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.13M Buy
275
+12
+5% +$51.7K 0.43% 78
2013
Q2 		$1.04M Buy
+263
New +$1.08M 0.4% 77

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Missouri Valley Partners's ACOR Position: Q3 2013 in Review

Missouri Valley Partners increased its Acorda Therapeutics (ACOR) stake by 4.6% in Q3 2013, buying an estimated $51.7K and bringing the position to 275 shares worth $1.13M. The position accounts for 0.43% of the portfolio, ranked #78.

Missouri Valley Partners first reported a position in ACOR in Q2 2013 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold ACOR as of Q3 2013.

  • Missouri Valley Partners held 275 shares of Acorda Therapeutics worth $1.13M as of Q3 2013.
  • Missouri Valley Partners bought 12 Acorda Therapeutics shares in Q3 2013, an estimated $51.7K.
  • Acorda Therapeutics made up 0.43% of Missouri Valley Partners's portfolio in Q3 2013, its #78 holding.
  • Missouri Valley Partners first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2013.

Based on Missouri Valley Partners's 13F filing for Q3 2013, filed 13 Nov 2013.